A mitochondrial lipid metabolism–related gene signature predicts prognosis and immune landscape in colorectal cancer
This mitochondrial lipid metabolism-based risk model represents a promising prognostic biomarker, offering potential guidance for personalized therapeutic strategies in CRC management.
Authors
- Hou Wang (ORCID: https://orcid.org/0000-0002-2066-1856)
- Mengyun Chen
- Yan Wang (ORCID: https://orcid.org/0000-0003-1761-8555)
- Kai Zhang (ORCID: https://orcid.org/0000-0003-2800-0531)
- Mingchen Zhang (ORCID: https://orcid.org/0000-0002-1002-3009)
Institutions
- Ruijin Hospital (CN)
- Ningbo No. 2 Hospital (CN)
- Shanghai Institute of Hematology (CN)
- Ningbo No.6 Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.3389/fimmu.2025.1669678
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00